Photoimmunotherapy of urological malignancies by Miltuximab®-IRDye700DX
USANZ ePoster Library. Polikarpov D. 03/08/20; 287742; 218
Dmitry Polikarpov
Dmitry Polikarpov
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
https://az659834.vo.msecnd.net/eventsairaueprod/production-dcconferences-public/0a2d0c2f93af4e0e9f8b0e87f881a059
https://az659834.vo.msecnd.net/eventsairaueprod/production-dcconferences-public/0a2d0c2f93af4e0e9f8b0e87f881a059
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings